Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software revision rather than a change to the ClinicalTrials.gov record history.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded revision: v3.5.2 to the history. Removed revision: v3.5.0 from the history.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry, v3.5.0, has been added to the history. The older entry, v3.4.3, has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new revision entry for Revision v3.4.3 and removed Revision v3.4.2 on the Record History page.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added to the history, indicating a new page version. The older funding notice and Revision: v3.4.1 were removed, reflecting routine maintenance of the record history.SummaryDifference0.5%

- Check98 days agoChange DetectedAdded a government funding/status notice banner and updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.